Literature DB >> 10549367

Structure and function of multidrug transporters.

H W van Veen1, W N Konings.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 10549367     DOI： 10.1007/978-1-4615-4897-3_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  8 in total

1.  Automated QSPR through Competitive Workflow.

Authors:  J Cartmell; S Enoch; D Krstajic; D E Leahy
Journal:  J Comput Aided Mol Des       Date:  2006-01-17       Impact factor: 3.686

2.  NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes.

Authors:  Jian-Lin Yu; Leo Grinius; David C Hooper
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

3.  Conformational equilibrium defines the variable induction of the multidrug-binding transcriptional repressor QacR.

Authors:  Koh Takeuchi; Misaki Imai; Ichio Shimada
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-16       Impact factor: 11.205

4.  Identification, cloning, and functional characterization of EmrD-3, a putative multidrug efflux pump of the major facilitator superfamily from Vibrio cholerae O395.

Authors:  Kenneth P Smith; Sanath Kumar; Manuel F Varela
Journal:  Arch Microbiol       Date:  2009-10-30       Impact factor: 2.552

5.  Catalytic transitions in the human MDR1 P-glycoprotein drug binding sites.

Authors:  John G Wise
Journal:  Biochemistry       Date:  2012-06-12       Impact factor: 3.162

6.  Dynamic multidrug recognition by multidrug transcriptional repressor LmrR.

Authors:  Koh Takeuchi; Yuji Tokunaga; Misaki Imai; Hideo Takahashi; Ichio Shimada
Journal:  Sci Rep       Date:  2014-11-18       Impact factor: 4.379

7.  Dynamic equilibrium on DNA defines transcriptional regulation of a multidrug binding transcriptional repressor, LmrR.

Authors:  Koh Takeuchi; Misaki Imai; Ichio Shimada
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

8.  MFS transporter from Botrytis cinerea provides tolerance to glucosinolate-breakdown products and is required for pathogenicity.

Authors:  David Vela-Corcía; Dhruv Aditya Srivastava; Avis Dafa-Berger; Neta Rotem; Omer Barda; Maggie Levy
Journal:  Nat Commun       Date:  2019-06-28       Impact factor: 14.919
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.